Enabling Data

References Didelot X, Bowden R, Wilson DJ, Peto TEA, Crook DW. Transforming clinical microbiology with bacterial genome sequencing. Nat Rev Genet. 2012;13:601–12. https://doi.org/10.1038/nrg3226. Article CAS PubMed PubMed Central Google Scholar Loman NJ, Pallen MJ. Twenty years of bacterial genome sequencing. Nat Rev Microbiol. 2015;13:787–94. https://doi.org/10.1038/nrmicro3565. Article CAS PubMed Google Scholar Goodwin S, McPherson JD, McCombie WR.

Summary Background Gonorrhoea is a rapidly growing public health threat, with rising incidence and increasing drug resistance. Evidence that the MeNZB and four-component serogroup B meningococcal (4CMenB) vaccines, designed against Neisseria meningitidis, can also offer protection against gonorrhoea has created interest in using 4CMenB for this purpose and for developing gonorrhoea-specific vaccines.